Yale University

Effect of early versus deferred antiretroviral therapy for HIV on survival.

TitleEffect of early versus deferred antiretroviral therapy for HIV on survival.
Publication TypeJournal Article
Year of Publication2009
AuthorsKitahata, Mari M., Stephen J. Gange, Alison G. Abraham, Barry Merriman, Michael S. Saag, Amy C. Justice, Robert S. Hogg, Steven G. Deeks, Joseph J. Eron, John T. Brooks, Sean B. Rourke, John M. Gill, Ronald J. Bosch, Jeffrey N. Martin, Marina B. Klein, Lisa P. Jacobson, Benigno Rodriguez, Timothy R. Sterling, Gregory D. Kirk, Sonia Napravnik, Anita R. Rachlis, Liviana M. Calzavara, Michael A. Horberg, Michael J. Silverberg, Kelly A. Gebo, James J. Goedert, Constance A. Benson, Ann C. Collier, Stephen E. Van Rompaey, Heidi M. Crane, Rosemary G. McKaig, Bryan Lau, Aimee M. Freeman, and Richard D. Moore
Corporate AuthorsNA-ACCORD Investigators
JournalThe New England journal of medicine
Date Published2009 Apr 30
KeywordsAdult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Confounding Factors (Epidemiology), Drug Administration Schedule, Female, HIV, HIV Infections, Humans, Male, Middle Aged, Proportional Hazards Models, Risk, RNA, Viral, Survival Analysis
AbstractThe optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain.
Alternate JournalN. Engl. J. Med.

External Links